Outset Medical, Inc. (OM) Dividend History

Outset Medical, Inc. is a healthcare technology company that develops and commercializes innovative dialysis solutions. Its flagship product, the Tablo Hemodialysis System, aims to simplify the delivery of dialysis treatment by integrating multiple functions into a compact, user-friendly device, improving access and efficiency for dialysis clinics and patients.

3052 Orchard Drive, San Jose, CA, 95134
Phone: 669-231-8200
Website:

Dividend History

Outset Medical, Inc. currently does not pay dividends

Company News

  • Outset Medical to Present at RBC Global Healthcare Conference

    Outset Medical, a medical technology company, announced that members of its management team will participate in the RBC Capital Markets Global Health Care conference on May 20, 2025. The company's Tablo Hemodialysis System, which is FDA-cleared for use from the hospital to the home, represents a significant technological advancement in the dialysis industry.

    GlobeNewswire Inc.
  • Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

    Outset Medical, a medical technology company, announced a one-for-fifteen reverse stock split. The company also plans to release its Q1 2025 financial results and host a conference call to discuss the results.

    GlobeNewswire Inc.
  • Outset Medical: Profitability Path Brightens

    Outset Medical reported strong Q4 earnings, with revenue and adjusted EPS beating analyst estimates. The company saw improved gross margins and reduced operating expenses, signaling progress towards profitability. Outset remains optimistic about future growth, projecting revenue of $115-$125 million by 2025.

    The Motley Fool
  • Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm

    Kuehn Law is investigating Outset Medical, Inc. (OM) for potential breach of fiduciary duties, alleging the company misrepresented or failed to disclose information about its Tablo products and their regulatory approval status.

    GlobeNewswire Inc.
  • Outset Medical to Present at the 2024 Stifel Healthcare Conference

    Outset Medical, a medical technology company, announced that members of its management team will present at the 2024 Stifel Healthcare conference on November 19, 2024. The company's Tablo Hemodialysis System, which is FDA-cleared for use from the hospital to the home, represents a significant technological advancement in the dialysis industry.

    GlobeNewswire Inc.
Dividend data last updated 06/07/2025 10:02:09 UTC